Table 1.
Recipient age, y (range) | 36 (13-56) |
---|---|
Donor age, y (range) | 36 (16-58) |
Sex, n (%) | |
Male | 11 (52) |
Female | 10 (48) |
Disease distribution | |
CML | 17 (81) |
AML/MDS | 3 (14) |
MM | 1 (5) |
Stem cell source | |
BM | 15 (71) |
PBSC | 6 (29) |
Acute GVHD grade II-IV | 6 (29) |
History of cGVHD | |
None | 3 (14) |
Limited | 13 (62) |
Extensive | 5 (24)* |
IST for cGVHD | |
> 3 years | 6 (29) |
At study | 1 (5) |
Follow-up period, years, median (range) | 12 (10-15) |
ALL indicates acute lymphoblastic leukemia; AML, acute myelogenous leukemia; cGVHD, chronic graft-versus-host disease; CML, chronic myelogenous leukemia; GVHD, graft-versus-host disease; IST, immunosuppressive therapy; MDS, myelodysplastic syndrome; and MM, multiple myeloma.
One recipient with active cGVHD at the time of study.